Outcome differences between males and females undergoing deep brain stimulation for treatment-resistant depression: systematic review and individual patient data meta-analysis.

Deep brain stimulation Major depressive disorder Neuromodulation Treatment-resistant depression

Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
29 Jan 2024
Historique:
received: 22 08 2023
revised: 22 01 2024
accepted: 26 01 2024
medline: 5 2 2024
pubmed: 5 2 2024
entrez: 31 1 2024
Statut: aheadofprint

Résumé

Treatment-resistant depression (TRD) occurs more commonly in women. Deep brain stimulation (DBS) is an emerging treatment for TRD, and its efficacy continues to be explored. However, differences in treatment outcomes between males and females have yet to be explored in formal analysis. A PRISMA-compliant systematic review of DBS for TRD studies was conducted. Patient-level data were independently extracted by two authors. Treatment response was defined as a 50 % or greater reduction in depression score. Percent change in depression scores by gender were evaluated using random-effects analyses. Of 737 records, 19 studies (129 patients) met inclusion criteria. The mean reduction in depression score for females was 57.7 % (95 % CI, 64.33 %-51.13 %), whereas for males it was 35.2 % (95 % CI, 45.12 %-25.23 %) (p < 0.0001). Females were more likely to respond to DBS for TRD when compared to males (OR = 2.44, 95 % CI 1.06, 1.95). These differences varied in significance when stratified by DBS anatomical target, age, and timeframe for responder classification. Studies included were open-label trials with small sample sizes. Our findings suggest that females with TRD respond at higher rates to DBS treatment than males. Further research is needed to elucidate the implications of these results, which may include connectomic sexual dimorphism, depression phenotype variations, or unrecognized symptom reporting differences. Methodological standardization of outcome scales, granular demographic data, and individual subject outcomes would allow for more robust comparisons between trials.

Sections du résumé

BACKGROUND BACKGROUND
Treatment-resistant depression (TRD) occurs more commonly in women. Deep brain stimulation (DBS) is an emerging treatment for TRD, and its efficacy continues to be explored. However, differences in treatment outcomes between males and females have yet to be explored in formal analysis.
METHODS METHODS
A PRISMA-compliant systematic review of DBS for TRD studies was conducted. Patient-level data were independently extracted by two authors. Treatment response was defined as a 50 % or greater reduction in depression score. Percent change in depression scores by gender were evaluated using random-effects analyses.
RESULTS RESULTS
Of 737 records, 19 studies (129 patients) met inclusion criteria. The mean reduction in depression score for females was 57.7 % (95 % CI, 64.33 %-51.13 %), whereas for males it was 35.2 % (95 % CI, 45.12 %-25.23 %) (p < 0.0001). Females were more likely to respond to DBS for TRD when compared to males (OR = 2.44, 95 % CI 1.06, 1.95). These differences varied in significance when stratified by DBS anatomical target, age, and timeframe for responder classification.
LIMITATIONS CONCLUSIONS
Studies included were open-label trials with small sample sizes.
CONCLUSIONS CONCLUSIONS
Our findings suggest that females with TRD respond at higher rates to DBS treatment than males. Further research is needed to elucidate the implications of these results, which may include connectomic sexual dimorphism, depression phenotype variations, or unrecognized symptom reporting differences. Methodological standardization of outcome scales, granular demographic data, and individual subject outcomes would allow for more robust comparisons between trials.

Identifiants

pubmed: 38296058
pii: S0165-0327(24)00271-4
doi: 10.1016/j.jad.2024.01.251
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

481-488

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal.

Auteurs

Ekta Patel (E)

University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA.

Priya Ramaiah (P)

University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA.

James C Mamaril-Davis (JC)

University of Arizona College of Medicine - Tucson, Tucson, AZ, USA.

Isabel L Bauer (IL)

University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA.

Dalia Koujah (D)

University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA.

Travis Seideman (T)

University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA.

James Kelbert (J)

University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA.

Kristin Nosova (K)

Department of Neurosurgery, Banner University Medical Center/University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA.

Robert W Bina (RW)

Department of Neurosurgery, Banner University Medical Center/University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA. Electronic address: rwbina@arizona.edu.

Classifications MeSH